Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) Overview

INFUSYSTEM HOLDINGS, INC (INFU) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.15; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.05; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.11; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.12; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$7.05$8.13$9.37$10.80$12.45$14.352025-11-062026-11-06$4.47$5.99$8.04$10.79$14.48$19.432021-11-082026-11-06$1.23$2.24$4.05$7.34$13.29$24.072016-11-072026-11-06$0.86$1.68$3.27$6.36$12.37$24.072007-12-272026-11-06$0.86$1.68$3.27$6.36$12.37$24.072007-12-272026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$13.67
Previous close
$13.03
Change
$0.64
Change (%)
4.91%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

INFU
+45.26%
S&P 500
(m)

1 year

INFU
+24.10%
S&P 500
(m)

3 years

INFU
+35.17%
S&P 500
(m)

5 years

INFU
-0.84%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.15

-0.090.010.120.220.3331 Mar 2025: estimate (m); actual -0.0131 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.1230 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.1130 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0531 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.1530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.15(m)(m)
1 Jan 202631 Mar 2026(m)0.05(m)(m)
1 Jul 202530 Sept 2025(m)0.11(m)(m)
1 Apr 202530 Jun 2025(m)0.12(m)(m)
1 Jan 202531 Mar 2025(m)-0.01(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.31

-0.080.060.200.350.4931 Dec 2021: estimate (m); actual 0.0631 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.0031 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.0431 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.1131 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.3131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.31(m)(m)
1 Jan 202431 Dec 2024(m)0.11(m)(m)
1 Jan 202331 Dec 2023(m)0.04(m)(m)
1 Jan 202231 Dec 2022(m)0.00(m)(m)
1 Jan 202131 Dec 2021(m)0.06(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 36.93M ■ Earnings 3.23M — Profit margin 8.75%

-4.43M2.0%10.83M4.6%26.10M7.2%41.36M9.7%30 Sept 2025: revenue 36.49M; earnings 2.26M; profit margin 6.19%30 Sept 202531 Dec 2025: revenue 36.23M*; earnings 2.04M*; profit margin 5.62%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 33.68M; earnings 1.02M; profit margin 3.02%31 Mar 202630 Jun 2026: revenue 36.93M; earnings 3.23M; profit margin 8.75%30 Jun 2026

31 Dec 2025 ■ Revenue 143.44M ■ Earnings 6.63M — Profit margin 4.62%

-17.21M-1.0%42.07M1.2%101.36M3.4%160.65M5.6%31 Dec 2022: revenue 109.91M; earnings 0.02M; profit margin 0.02%31 Dec 202231 Dec 2023: revenue 125.78M; earnings 0.87M; profit margin 0.69%31 Dec 202331 Dec 2024: revenue 134.86M; earnings 2.35M; profit margin 1.74%31 Dec 202431 Dec 2025: revenue 143.44M; earnings 6.63M; profit margin 4.62%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$13.67(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$13.67High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning INFU

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$8.54M
Profit margin
5.96%
Return on assets · 12 month
8.61%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
473.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
143.31K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-0.61%*
Total return · month
8.22%*
Total return · quarter
31.88%*
Total return · half year
36.58%*
Total return · year to date
45.26%*
Total return · 1 year
24.10%*
Total return · 3 years
35.17%*
Total return · 5 years
-0.84%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$143.34M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
34.53%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

INFUSYSTEM HOLDINGS, INC Overview

View more →

(m)

(m)

SEC CIK
1337013
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
3851 WEST HAMLIN ROAD, ROCHESTER HILLS, Michigan, 48309, United States
Fiscal year end
1231
Phone
(248) 291-1210

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37